Crizler Injection 2 mg/2 ml contains Vincristine Sulfate, a potent anticancer medication belonging to the vinca alkaloid class. It is widely used in oncology as part of combination chemotherapy regimens for treating different types of cancers, especially blood-related malignancies and certain solid tumors.
Vincristine works by interfering with cancer cell division, helping to slow or stop tumor growth. It is administered only under strict medical supervision in hospital settings.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Composition
Each 2 ml vial contains:
It is intended for intravenous (IV) administration only and must never be given intrathecally (into the spinal fluid), as this can be fatal.
Mechanism of Action
Vincristine works by disrupting the process of cell division:
-
Binds to tubulin, a protein required for microtubule formation
-
Prevents formation of the mitotic spindle
-
Stops cancer cells from dividing during metaphase
-
Leads to cell death in rapidly growing cancer cells
This makes it effective in controlling fast-growing cancers.
Indications
Crizler Injection is indicated for the treatment of:
-
Acute Lymphoblastic Leukemia
-
Non-Hodgkin Lymphoma
-
Hodgkin Lymphoma
-
Wilms Tumor
-
Neuroblastoma
It is usually used in combination chemotherapy protocols.
Dosage and Administration
-
Administered intravenously only by trained healthcare professionals
-
Dosage depends on body weight, cancer type, and treatment regimen
-
Given at scheduled intervals as part of chemotherapy cycles
-
Strict precautions are required during administration
Benefits
Crizler Injection offers important therapeutic benefits:
-
Effective against multiple cancers
-
Works well in combination chemotherapy regimens
-
Helps slow cancer progression
-
Improves survival outcomes in certain cancers
-
Essential drug in pediatric oncology protocols
Possible Side Effects
Common side effects include:
-
Hair loss (alopecia)
-
Constipation
-
Nerve pain or tingling (peripheral neuropathy)
-
Fatigue
Serious side effects:
-
Severe nerve damage (dose-related neuropathy)
-
Constipation leading to bowel obstruction
-
Low white blood cell count (in combination therapy)
Precautions
-
Strictly for IV use only—never intrathecal administration
-
Regular monitoring of blood counts is required
-
Use cautiously in patients with pre-existing nerve disorders
-
Dose adjustment may be needed in liver impairment
-
Avoid pregnancy during treatment due to risk of fetal harm
Storage
Store in a refrigerated environment (2–8°C) and protect from light. Handle only by trained medical personnel.